Syphilis Screen with Titer

Syphilis is one of the oldest known sexually transmitted infections, and it is surging. The United States recorded over 207,000 total syphilis cases in 2022, the highest number in decades, with primary and secondary cases rising sharply over the past several years. The disease progresses through stages, can go dormant for years, and damages the heart, brain, and nervous system if left untreated. A single screening test tells you whether antibodies are present. But a screening test alone cannot tell you how active the infection is, whether treatment worked, or whether the disease is coming back. That is what the titer adds.

The RPR (Rapid Plasma Reagin) Monitor with Reflex to Titer combines two steps in a single order. First, it runs a qualitative screen: reactive or nonreactive. If the screen comes back reactive, the lab automatically measures a quantitative titer, a number that reflects how much antibody your immune system is producing against the infection. Together, these two results answer the questions that matter most: Is there an active infection? Is treatment working? Has the infection returned?

What This Panel Reveals

The RPR test detects a type of antibody called reagin. Your body produces reagin when syphilis bacteria (Treponema pallidum) damage tissue and release lipid material into the bloodstream. The immune system reacts to that material, and the RPR measures the strength of that reaction. This makes the RPR a nontreponemal test, meaning it does not look for antibodies against the syphilis bacterium itself, but rather for antibodies triggered by the tissue damage syphilis causes.

The screen tells you whether reagin antibodies are detectable at all. A nonreactive result generally means no current or recent syphilis infection, though very early infection (within the first one to two weeks of a chancre, the painless sore that marks the earliest stage of syphilis) can produce a false negative. A reactive result means antibodies were detected and the titer is needed to understand what that means clinically.

The titer is reported as a ratio: 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, and so on. Each step represents a twofold dilution of the blood sample. A titer of 1:32 means the sample had to be diluted 32 times before the antibodies became undetectable, indicating a strong immune response. A titer of 1:1 means antibodies are barely detectable. Higher titers generally correlate with more active disease, while lower titers may reflect treated or latent infection.

How to Read Your Results Together

The value of this panel comes from reading the screen and titer as a pair, and especially from comparing titers over time. A single titer is a snapshot. Serial titers reveal a trajectory.

The fourfold decline is the gold standard for confirming treatment success. After appropriate antibiotic therapy for primary or secondary syphilis, the CDC considers a fourfold (two dilution) drop in RPR titer within 6 to 12 months as evidence of adequate treatment. For example, a titer that drops from 1:16 to 1:4 represents a fourfold decline. A titer that only drops from 1:16 to 1:8 does not meet this threshold and may warrant retreatment or closer follow up.

Some people who have been treated successfully never return to a nonreactive result. Their titer stabilizes at a low level (typically 1:1 to 1:4) and stays there indefinitely. This is called being serofast. It does not mean the infection is active. It means the immune memory persists. This is one reason why serial titers matter: if your baseline serofast titer is 1:2, and a new test shows 1:8, that fourfold rise signals possible reinfection.

When Results Can Be Misleading

The RPR is not specific to syphilis. Because it measures antibodies to tissue damage rather than to the bacteria itself, several other conditions can trigger a reactive result without syphilis being present. These are called biological false positives, and they occur in an estimated 1% to 2% of the general population.

Conditions known to cause false positive RPR results include pregnancy, autoimmune diseases (particularly systemic lupus erythematosus), acute viral infections (such as hepatitis, mononucleosis, or HIV), intravenous drug use, and advanced age. A reactive RPR screen should always be confirmed with a treponemal test, such as the FTA-ABS (fluorescent treponemal antibody absorption) or TP-PA (Treponema pallidum particle agglutination), which detects antibodies directed specifically against the syphilis organism.

False negatives can also occur. In very early primary syphilis (the first week or two after a chancre appears), the immune response may not yet be strong enough to register on the RPR. In late latent syphilis, titers may be very low or occasionally nonreactive. A phenomenon called the prozone effect can also cause a false negative: when antibody levels are extremely high, the test chemistry can paradoxically fail to detect them unless the lab dilutes the sample further. Most modern labs are aware of this and dilute samples when clinical suspicion is high.

Tracking Over Time

The RPR titer is one of the few lab values where the trend matters more than any single number. A reactive screen with a titer of 1:4 can mean very different things depending on context. If your titer was 1:32 three months ago, a 1:4 now is excellent news. If your titer was 1:1 six months ago, a 1:4 now is concerning.

After treatment for primary or secondary syphilis, the CDC recommends RPR titer monitoring at 6 and 12 months. For latent syphilis, monitoring extends to 6, 12, and 24 months. People living with HIV who are treated for syphilis should be monitored at 3, 6, 9, 12, and 24 months due to a higher risk of treatment failure. Anyone with ongoing sexual risk factors for syphilis should consider screening at least annually, and every 3 to 6 months if sexually active with multiple partners.

Serial testing also catches reinfection. Syphilis does not confer lasting immunity. You can be reinfected after successful treatment. A fourfold rise in titer from a previously stable baseline is the standard definition of reinfection or relapse and warrants immediate evaluation and retreatment.

What to Do with Your Results

If your RPR screen is nonreactive and you have no symptoms or known exposures, no further testing is needed at this time. Continue screening based on your risk profile.

If your RPR screen is reactive with any titer, the next step is a confirmatory treponemal test. A positive confirmatory test confirms syphilis infection (current or past). A negative confirmatory test suggests the RPR was a biological false positive. If syphilis is confirmed and you have not been treated, antibiotic therapy (typically penicillin) should begin promptly, followed by serial RPR titers to verify treatment response.

If you are monitoring after treatment and your titer has not declined fourfold within the expected window, discuss retreatment with a physician. If your titer rises fourfold from a stable baseline, seek evaluation for reinfection. If you have neurological symptoms such as vision changes, hearing loss, or confusion alongside a reactive RPR, a spinal fluid test may be needed to rule out neurosyphilis, a condition in which syphilis has reached the brain and spinal cord.